APPLICATION OF IMMUNOCORREGITIVE THERAPY IN FREQUENTLY ILL CHILDREN

Abstract

This paper presents data from a study of the effectiveness of long-term antirelapse therapy in frequently ill children based on the complex use of the immunocorrective
drug Broncho-munal. To achieve the objectives, anti-relapse effectiveness was determined
by three parameters: incidence rate, frequency of relapses of infections and prolongation of
remission periods.